After reading this article, the participant should be able to: 1. Develop a practical method for preoperative implant size selection. 2. List characteristics and examples of fourth- and fifth-generation silicone implants. 3. Recognize the differences in “profile” designations across implant manufacturers. 4. Recall updated statistics on breast implant–associated anaplastic large cell lymphoma and describe current guidelines on disease diagnosis and treatment. 5. Apply atraumatic and aseptic surgical techniques in primary breast augmentation.
Modern primary breast augmentation requires an intimate knowledge of the expanding breast implant market, including characteristics of current generation silicone implants and “profile” types. Optimal implant size selection requires balancing patient desires with tissue qualities. Evidence and awareness of breast implant–associated anaplastic large cell lymphoma continue to grow, and patients and surgeons alike should be informed on the most updated facts of the disease entity. Atraumatic surgical technique and aseptic adjuncts are critical in reducing periprosthetic inflammation and contamination, both of which are known instigators of capsular contracture and potentially breast implant–associated anaplastic large cell lymphoma.
Related Video Content is Available Online.
From the Dallas Plastic Surgery Institute.
Received for publication May 27, 2018; accepted July 16, 2018.
Disclosure: Dr. Rohrich receives instrument royalties from Eriem Surgical, Inc., and book royalties from Thieme Medical Publishing. He is a clinical and research expert for Allergan, Inc., and MTF Biologics, and the owner of Medical Seminars of Texas, LLC. Dr. Wan has no financial interest to declare in relation to the content of this article. No funding was received for this article.
Related Video content is available for this article. The videos can be found under the “Related Videos” section of the full-text article, or, for Ovid users, using the URL citations published in the article.
Rod J. Rohrich, M.D., 9101 North Central Expressway, Suite 600, Dallas, Texas 75231, email@example.com, Twitter: @DrRodRohrich, Instagram: @Rod.Rohrich